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Background: Cardiac surgery is the recommended treatment for
patients with left main (LM) disease, although percutaneous coronary inter-
vention (PCI) is emerging as an alternative technique. Stent thrombosis
(ST) even if rare is a serious complication after PCI with high rate of mor-
tality. Aggregation tests can identify patients with high platelet reactivity
under clopidogrel and aspirin. The objective of this registry was to evaluate
the 2-years rate of ST and outcomes in patients with PCI for unprotected
LM disease and adapted dual antiplatelet therapy (DAPT) according to
aggregation tests.
Methods and results: Fifty one patients with LM disease were pro-
spectively included in a single center registry. Acute myocardial infarction
(MI) and cardiogenic shock were exclusion criteria. DAPT response was
evaluated by VASP index and light transmission aggregometry (LTA) with
acid arachidonic acid (AA 0.5 mg/ml) and with adenosine diphosphate
(ADP 20 µmol/L). Patients were 67±12 years old, 52% were diabetic, 33%
admitted for acute coronary syndrome and 61% had multivessel disease.
For distal LM lesions (73%), the provisional T-stenting approach was used
in all cases with 84% of final kissing balloon inflation and 20% of T stenting.
27% patients were aspirin non responders (LTA-AA 0.5 mg/ml≥20%) and
47% clopidogrel non responders according to VASP index (≥50%). After
optimization of DAPT, aspirin was given twice a day in 27% of patients,
prasugrel in 45%, clopidogrel high dose (≥150 mg) in 35% and clopidogrel
standard dose (75 mg) in only 20%. At 2 years, no ST occurred. Outcomes
were 24% with 3 non Q-wave MI (6%), 2 cerebrovascular accidents (4%),
and 7 repeat revascularizations (14%) with 4 target lesion revasculariza-
tion (8%). Mortality rate was 4% (n=2) with one cardiovascular death
(2%).
Conclusion: Unprotected LM stenting and systematic platelet function
assessment with DAPT optimization provides excellent clinical outcomes
without any stent thrombosis at 2 years.
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Purposes: to investigate relationship between the intima-media thickness
of the common carotid artery (CCIMT) and diabetic dyslipidemia in patients
with ischemic heart disease (IHD) and type 2 diabetes mellitus (T2DM).
Methods. We examined 60 patients with IHD (25 males, age 60.5±4.7
years). Baseline characteristics of patients included history of IHD (7.2±2.3
years), 30 of them have T2DM (4.7±0.5 years). The level of HbA1c was less
than 7.5%. In all patients were determined the levels of total cholesterol (TC),
low-density lipoprotein cholesterol (LDL), very LDL (VLDL), triglycerides
(TG), high-density lipoprotein cholesterol (HDL) by enzymatic colorymetric
method, CCIMT by Carotid Doppler Ultrasonography. All patients received
the standard therapy included 20 mg atorvastatin once daily. The control
group includes 20 healthy volunters.
Results. All patients with IHD had significantly higher levels of TC,
LDL, VLDL and significantly lower levels of HDL as compare with
control group and there were no significant differences between diabetic
patients and patients without T2DM. The study found that among patients
with T2DM dominated combined dyslipidemia, which was manifested in
an additional increase of TG level (p<0,05). CCIMT were significantly
higher in diabetic patients with hypertriglyceridemia (hTG) (p<0,05).
CCIMT was significantly correlated with age in nondiabetic patients
(r=0,69, p<0,05) and diabetic patients (r=0,43, p<0,05). CCIMT was sig-
nificantly more increased in patients with T2DM and hTG as compare with
diabetic patients with normal levels of TG (p<0,05). In patients with
T2DM was positive correlation between CCIMT and duration of T2DM
(r=0,41, p<0,05).
Conclusions: CCIMT was significantly more increased in diabetic patients
with hTG and depend on duration of T2DM.
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Figure: Aggregation tests results in the population (n=51)
